Skip to main content

Closed

DNA: Ginkgo Bioworks Holdings, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-210.7%

ROIC-31.1%

Financially safe

Stretched

Debt / equity0.93×

Interest coverage0.0×

Current ratio5.15×

Ginkgo Bioworks Holdings, Inc.

DNANew York Stock Exchange·USD·Closed

Ginkgo Bioworks Holdings, Inc.

DNANew York Stock Exchange·USD·Closed

$8.09

+0.00%

$8.09

+$0.00 (0.00%)

52W Range

22thpctl

Volume

0.51×avg

Mkt Cap

528.48MUSD

P/E

-1.5TTM

Div Yield

–ann

52W Range

22thpctl

Volume

0.51×avg

Market Cap

528.48MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings